Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg

NCT03902574 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Otsuka Pharmaceutical Co., Ltd.